-Carlos Caldas Researcher Activity Profile

Research Author Detailed Information 

Carlos Caldas Publication Rate By Year

Carlos Caldas has published 11 paper(s) in 2007, 8 paper(s) in 2008, for a total of 19 research publications in total.

Carlos C Caldas Author Information

LAST NAME: caldas

FIRST NAME: carlos

INITIALS: C

AFFILIATION:

Papers

Carlos Caldas's Publication Record

1. Pathology findings and validation of gastric and esophageal cancer cases in a European cohort (EPIC/EUR-GAST). Year Published: 2007
Institute of Molecular Pathology and Immunology of the University of Porto, Portugal, and Hutchison/MRC Research Centre, Addenbrooke's Hospital, Cambridge, UK. fcarneiro@ipatimup.pt
2. Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Year Published: 2007
Department of Academic Oncology, King's College London and Guy's & St Thomas' NHS Foundation Trust, United Kingdom.
3. Regulation of p53 tetramerization and nuclear export by ARC. Year Published: 2007
Departments of Medicine and Cell Biology, Cardiovascular Research Center, and Cancer Center, Albert Einstein College of Medicine, Bronx, NY 10461.
4. MicroRNA-implications for cancer. Year Published: 2007
Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Research Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK, stefanie.sassen@cancer.org.uk.
5. Elucidating the altered transcriptional programs in breast cancer using independent component analysis. Year Published: 2007
Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Research Institute, Cambridge, United Kingdom. aet21@cam.ac.uk
6. The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Year Published: 2007
Functional Genomics of Drug Resistance Laboratory, Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
7. An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Year Published: 2008
Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Research Institute and Department of Oncology, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. aet21@cam.ac.uk.
8. Regulation of p53 tetramerization and nuclear export by ARC. Year Published: 2007
Departments of Medicine and Cell Biology, Cardiovascular Research Center, and Cancer Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
9. Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Year Published: 2007
Department of Academic Oncology, King's College London and Guy's & St Thomas' NHS Foundation Trust, United Kingdom.
10. Regulation of p53 tetramerization and nuclear export by ARC. Year Published: 2007
Departments of Medicine and Cell Biology, Cardiovascular Research Center, and Cancer Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
11. The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Year Published: 2007
Functional Genomics of Drug Resistance Laboratory, Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
12. An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Year Published: 2008
Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Research Institute and Department of Oncology, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. aet21@cam.ac.uk.
13. An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Year Published: 2008
Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Research Institute and Department of Oncology, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. aet21@cam.ac.uk
14. The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Year Published: 2007
Functional Genomics of Drug Resistance Laboratory, Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
15. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Year Published: 2008
Cancer Research UK, Cambridge Research Institute, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. cb391@cam.ac.uk.
16. High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Year Published: 2008
Breast Cancer Functional Genomics, Cancer Research UK Cambridge Research Institute and Department of Oncology University of Cambridge, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. sc10021@cam.ac.uk.
17. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Year Published: 2008
Cancer Research UK, Cambridge Research Institute, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. cb391@cam.ac.uk
18. High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Year Published: 2008
Breast Cancer Functional Genomics, Cancer Research UK Cambridge Research Institute and Department of Oncology University of Cambridge, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. sc10021@cam.ac.uk
19. Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies. Year Published: 2008
Institute of Molecular Pathology and Immunology of the University of Porto, University of Porto, Porto, Portugal.